EligibleTrials

Clinical trials recruiting for Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma

Fewer than 3 recruiting trials found.

1
Recruiting trials
1
US states with sites
1
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 1

Drugs and treatments being studied

InterventionTrials
Talazoparib Tosylate1
Trifluridine and Tipiracil Hydrochloride1

Where trials are recruiting (top US states)

StateRecruiting trials
New York1

Top cities

Buffalo, New York 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.

Stage IVC Colorectal Cancer AJCC v8 7Stage IVB Colorectal Cancer AJCC v8 7Stage IVA Colorectal Cancer AJCC v8 7Stage IV Colorectal Cancer AJCC v8 21Stage IIIC Colorectal Cancer AJCC v8 3Stage III Colorectal Cancer AJCC v8 10Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 3Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 3Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 3Metastatic Gastroesophageal Junction Adenocarcinoma 4

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.